TFF PHARMACEUTICALS, INC. Operating Expenses
TFF PHARMACEUTICALS, INC. reported Operating Expenses of $3.78 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. operating expenses for the quarter ending 2024-09-30 was $3.78M, a 18.90% decline year-over-year.
- TFF PHARMACEUTICALS, INC. operating expenses for the quarter ending 2024-06-30 was $4.61M, a 13.82% decline year-over-year.
- TFF PHARMACEUTICALS, INC. operating expenses for the quarter ending 2024-03-31 was $5.99M, a 16.02% decline year-over-year.
- TFF PHARMACEUTICALS, INC. operating expenses for the quarter ending 2023-12-31 was $5.48M, a 28.73% decline year-over-year.
- TFF PHARMACEUTICALS, INC. operating expenses for fiscal 2023 was $22.63M, a 29.93% decline from fiscal 2022.
- TFF PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $32.29M, a 1.31% increase from fiscal 2021.
- TFF PHARMACEUTICALS, INC. operating expenses for fiscal 2021 was $31.87M, a 70.51% increase from fiscal 2020.
- TFF PHARMACEUTICALS, INC. operating expenses for fiscal 2020 was $18.69M, a 55.94% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 11 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $3.78M 10-Q · filed 2024-11-20 | $8.39M derived: sum of 2 quarters · filed 2024-11-20 | $14.38M 10-Q · filed 2024-11-20 | $19.87M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2024-06-30 | $4.61M 10-Q · filed 2024-08-14 | $10.61M 10-Q · filed 2024-08-14 | $16.09M derived: sum of 3 quarters · filed 2024-08-14 | $20.75M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2024-03-31 | $5.99M 10-Q · filed 2024-05-14 | $11.48M derived: sum of 2 quarters · filed 2024-05-14 | $16.13M derived: sum of 3 quarters · filed 2024-11-20 | $21.48M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2023-12-31 | $5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $10.14M derived: sum of 2 quarters · filed 2024-11-20 | $15.49M derived: sum of 3 quarters · filed 2024-11-20 | $22.63M 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | $4.66M 10-Q · filed 2024-11-20 | $10.01M derived: sum of 2 quarters · filed 2024-11-20 | $17.15M 10-Q · filed 2024-11-20 | $24.84M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2023-06-30 | $5.35M 10-Q · filed 2024-08-14 | $12.49M 10-Q · filed 2024-08-14 | $20.18M derived: sum of 3 quarters · filed 2024-08-14 | $27.55M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $7.14M 10-Q · filed 2024-05-14 | $14.83M derived: sum of 2 quarters · filed 2024-05-14 | $22.20M derived: sum of 3 quarters · filed 2024-05-14 | $30.98M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $15.06M derived: sum of 2 quarters · filed 2024-03-28 | $23.84M derived: sum of 3 quarters · filed 2024-03-28 | $32.29M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $7.37M 10-Q · filed 2023-11-14 | $16.15M derived: sum of 2 quarters · filed 2023-11-14 | $24.60M 10-Q · filed 2023-11-14 | $34.71M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $8.78M 10-Q · filed 2023-08-14 | $8.80M 10-Q · filed 2022-08-11 | $17.23M 10-Q · filed 2023-08-14 | $17.31M 10-Q · filed 2022-08-11 | $27.34M derived: sum of 3 quarters · filed 2023-08-14 | $36.07M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $8.45M 10-Q · filed 2023-05-11 | $8.51M 10-Q · filed 2022-05-11 | $18.56M derived: sum of 2 quarters · filed 2023-05-11 | $27.29M derived: sum of 3 quarters · filed 2023-05-11 | $32.40M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $10.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $18.84M derived: sum of 2 quarters · filed 2023-03-31 | $23.95M derived: sum of 3 quarters · filed 2023-03-31 | $31.87M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $8.73M 10-Q · filed 2022-11-14 | $13.84M derived: sum of 2 quarters · filed 2022-11-14 | $21.77M 10-Q · filed 2022-11-14 | $27.69M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $5.11M 10-Q · filed 2022-08-11 | $13.04M 10-Q · filed 2022-08-11 | $18.96M derived: sum of 3 quarters · filed 2022-08-11 | $24.04M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $7.93M 10-Q · filed 2022-05-11 | $13.84M derived: sum of 2 quarters · filed 2022-05-11 | $18.92M derived: sum of 3 quarters · filed 2022-05-11 | $22.77M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $11.00M derived: sum of 2 quarters · filed 2022-03-24 | $14.84M derived: sum of 3 quarters · filed 2022-03-24 | $18.69M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $5.08M 10-Q · filed 2021-11-15 | $8.92M derived: sum of 2 quarters · filed 2021-11-15 | $12.77M 10-Q · filed 2021-11-15 | $17.49M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $3.84M 10-Q · filed 2021-08-12 | $7.70M 10-Q · filed 2021-08-12 | $12.41M derived: sum of 3 quarters · filed 2021-08-12 | $15.27M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $3.85M 10-Q · filed 2021-05-13 | $8.57M derived: sum of 2 quarters · filed 2021-05-13 | $11.43M derived: sum of 3 quarters · filed 2021-05-13 | $13.64M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $7.58M derived: sum of 2 quarters · filed 2021-03-10 | $9.79M derived: sum of 3 quarters · filed 2021-03-10 | $11.99M 10-K · filed 2021-03-10 | ||||
| 2019-09-30 | $2.86M 10-Q · filed 2020-11-05 | $5.07M derived: sum of 2 quarters · filed 2020-11-05 | $7.28M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $2.21M 10-Q · filed 2020-08-13 | $4.41M 10-Q · filed 2020-08-13 | ||||||
| 2019-03-31 | $2.20M 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | $3.90M 10-K · filed 2020-03-27 | |||||||
| 2018-09-30 | $606.09K 10-Q · filed 2019-12-09 | $3.00M 10-Q · filed 2019-12-09 |